{
  "docId": "019de073-4472-76ed-a8f3-3d6ae669b88a",
  "docSlug": "6078678dfcf31020360c86ce90f559c0",
  "documentTitle": "BioNTech | Results Presentation Deck | 32 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 32,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a process-oriented layout to show how three workstreams converge into a single launch event.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-4472-76ed-a8f3-3d6ae669b88a/11",
  "deckHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a",
  "deckJsonHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a.json",
  "deckAnchorHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.16,
        "x": 0.8,
        "y": 0.36
      },
      "kind": "callout",
      "text": "Planned Launch: First shipments expected as early as October subject to regulatory approval",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d2ca631-6cf3-4cea-b88b-aca86d19c16b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.19,
        "y": 0.2
      },
      "kind": "list",
      "text": "Regulatory Engagement: FDA/EMA guidance and submissions for BA.1 and BA.4/5 vaccines.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30adf22f-4ec1-449f-94b0-7118d6d5db4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.19,
        "y": 0.45
      },
      "kind": "list",
      "text": "Clinical Development: Trial for BA.4/5 vaccine starting in August.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49357d2e-f289-4cda-b3ca-09c74f303058",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.19,
        "y": 0.68
      },
      "kind": "list",
      "text": "Manufacturing Scale-Up: Production initiated for fall booster campaign.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6379332a-0f56-4ea9-85ce-344444e2a6c0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.04,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "CMC, chemistry, manufacturing, and controls",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11e94e5a-86ad-4b64-bffb-99c8c019749a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.75,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Preparing for Launch of Omicron-Adapted Bivalent Vaccines in Early October 2022",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8465e8f8-2064-4b87-86a1-d30333e7a86f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "e825b9f0-4c25-407b-a01e-dae1a96bcc64",
      "evidence": "The slide maps three distinct workstreams (Regulatory, Clinical, Manufacturing) converging into a single milestone (Launch).",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 16,
      "from": 10,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "caf53cc9-d49f-4125-a4b5-522d3d0ef84c",
      "evidence": "The presentation highlights the risks of not updating vaccines and the benefits of BioNTech's solutions",
      "position": 0,
      "objective": "What are the consequences of not adapting to evolving COVID-19 variants?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}